OPEN END TURBO BULL OPTIONSSCHEIN - IPSEN | Delayed Deutsche Boerse AG 13:27:04 2024-05-21 EDT | ||
| 2.35 EUR | 0.00% |
|
| Current month | +35.06% | ||
| 1 month | +94.21% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
IPSEN
| Date | Price | Change |
|---|---|---|
| 24-05-21 | 2.35 | 0.00% |
| 24-05-20 | 2.35 | +2.17% |
| 24-05-17 | 2.3 | -2.54% |
| 24-05-16 | 2.36 | +0.85% |
| 24-05-15 | 2.34 | -1.68% |
Delayed Quote Deutsche Boerse AG
Last update May 21, 2024 at 01:27 pm
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | IPSEN |
| Issuer | 
UniCredit
|
| WKN | HC2MML |
| ISIN | DE000HC2MML1 |
| Date issued | 2022-12-16 |
| Strike | 98.77 € |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.19 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.85 € |
|---|---|
| Lowest since issue | 0.61 € |
| Spread | 0.22 € |
| Spread % | 8.70% |
Company Profile
Ipsen specialises in the research, development, manufacture and marketing of specialty medicines. Net sales by therapeutic area break down as follows:
- oncology (75.2%);
- neuroscience (21.1%);
- rare diseases (3.7%).
At the end of 2023, the group had 4 research and development centres located in France, the United Kingdom, the United States and China, and 4 manufacturing sites worldwide.
Net sales are distributed geographically as follows: Europe (40.2%), North America (33.3%) and other (26.5%).
Sector
-
Consensus: Ipsen
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
121.3
EUR
Average target price
126.3
EUR
Spread / Average Target
+4.15%
- Stock Market
- Certificates
- Certificat
